Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedNo
Data checks8 of 8 passed
Key figures · 31
MetricValuePeriodScopeSource row
Operating income−¥949m2023-04-01 → 2023-12-31StandaloneOperating income
Operating income−¥1.0bn2022-04-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥971m2023-04-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥1.3bn2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.0bn2022-04-01 → 2022-12-31StandaloneOrdinary income
Profit before tax−¥971m2023-04-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax−¥1.0bn2022-04-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥973m2023-04-01 → 2023-12-31StandaloneProfit loss
Net income−¥1.3bn2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income−¥1.0bn2022-04-01 → 2022-12-31StandaloneProfit loss
Total assets¥1.8bnat 2023-12-31StandaloneAssets
Total assets¥907mat 2023-03-31StandaloneAssets
Total assets¥953mat 2022-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥91mat 2023-12-31StandaloneLiabilities
Total liabilities¥116mat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.7bnat 2023-12-31StandaloneNet assets
Net assets / equity¥791mat 2023-03-31StandaloneNet assets
Net assets / equity¥751mat 2022-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥1.7bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥844mat 2023-03-31StandaloneCash and deposits
EPS (basic)¥-142.092023-04-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-49.842023-10-01 → 2023-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-234.512022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-190.182022-04-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-75.042022-10-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio94.8%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio87.0%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.4%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued8,229,900at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued6,369,600at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued6,054,700at 2022-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 219
ItemContextValueUnit
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)Delta-Fly Pharma株式会社
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の5
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Description of fact that consolidated financial statements have not been prepared financial informationCurrentYTDDuration
Original text (Japanese)当社は子会社がありませんので、四半期連結財務諸表を作成しておりません。
Quarterly balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end statement of income (text)CurrentYTDDurationText · Plus
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes when there is significant changes in amounts of equity (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Notes when there is significant changes in amounts of equity (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes segment information etc quarterly financial statements (text)CurrentYTDDurationText · Plus
Description of fact that companys business comprises single segmentCurrentYTDDuration_NonConsolidatedMember
Original text (Japanese)当社は、医薬品事業のみの単一セグメントであるため、記載を省略しております。
Notes revenue recognition quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly financial statements (text)CurrentYTDDurationText · Plus
Other information financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 8 of 8 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass